Mission Momentum Aba, Inc. in Grand Island, FL - Behavior Analyst

Mission Momentum Aba, Inc. is a mental health clinic (Behavior Analyst) in Grand Island, Florida. The current practice location for Mission Momentum Aba, Inc. is 2475 Plumadore Dr, Grand Island, Florida. For appointments, you can reach them via phone at (321) 279-2443. The mailing address for Mission Momentum Aba, Inc. is 2475 Plumadore Dr, Grand Island, Florida and phone number is (321) 279-2443.

Mission Momentum Aba, Inc. is licensed to practice in * (Not Available) (license number ) and its NPI number is 1194415612. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (321) 279-2443.

Contact Information

	Mission Momentum Aba, Inc.
	2475 Plumadore Dr Grand Island FL 32735-9012
	(321) 279-2443
	Not Available

Mental Health Clinic Profile

Full Name	Mission Momentum Aba, Inc.
Speciality	Behavior Analyst
Location	2475 Plumadore Dr, Grand Island, Florida
Authorized Official Name and Position	Brooke Manion (BCBA)
Authorized Official Contact	3212792443
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mission Momentum Aba, Inc. 2475 Plumadore Dr Grand Island FL 32735-9012 Ph: (321) 279-2443	Mission Momentum Aba, Inc. 2475 Plumadore Dr Grand Island FL 32735-9012 Ph: (321) 279-2443

NPI Details:

NPI Number	1194415612
Provider Enumeration Date	05/09/2023
Last Update Date	05/09/2023
Certification Date	05/09/2023

Medical Identifiers

Medical identifiers for Mission Momentum Aba, Inc. such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194415612	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103K00000X	Behavior Analyst	(* (Not Available))	Primary

News Archive

FDA approves Lupin's SUPRAX capsules

Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. has received approval for SUPRAX (Cefixime) Capsules 400 mg from the United States Food and Drugs Administration (FDA).

Discovery of protein complex that plays important role in organ formation, cellular development and cicatrisation processes

Cellular movements are essential in organ formation processes, in cellular development and cicatrisation processes.

White House left states on their own to buy ventilators. Inside their mad scramble.

Fearful that New Orleans would run out of ventilators by early April as the number of COVID-19 patients rose by the hundreds, even thousands, per day, Louisiana officials set out to get every device they could find. At the time, that meant securing an additional 14,000.

Sysmex America, Henry Schein sign three-year distribution agreement

Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, and Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today announced the signing of a three-year distribution agreement between the companies effective immediately.

Upcoming phase II study to discover personalized therapy for patients at high risk for breast cancer relapse

Indiana University School of Medicine researchers Milan Radovich, PhD, and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women's blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative breast cancer are critical indicators for the prediction of disease recurrence and disease-free survival.

Mission Momentum Aba, Inc. - Mental Health Clinic in Grand Island, FL